A detailed history of Seven Mile Advisory transactions in Novartis Ag stock. As of the latest transaction made, Seven Mile Advisory holds 3,742 shares of NVS stock, worth $409,299. This represents 0.29% of its overall portfolio holdings.

Number of Shares
3,742
Previous 3,673 1.88%
Holding current value
$409,299
Previous $355 Million 12.13%
% of portfolio
0.29%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$92.57 - $107.37 $6,387 - $7,408
69 Added 1.88%
3,742 $398 Million
Q1 2024

May 08, 2024

BUY
$95.27 - $108.47 $5,239 - $5,965
55 Added 1.52%
3,673 $355 Million
Q4 2023

Feb 09, 2024

BUY
$92.27 - $101.54 $20,668 - $22,744
224 Added 6.6%
3,618 $365 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $8,052 - $8,936
-85 Reduced 2.44%
3,394 $346 Million
Q2 2023

Aug 08, 2023

BUY
$92.52 - $104.91 $321,877 - $364,981
3,479 New
3,479 $351 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.